These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 33462068

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Guillain-Barré syndrome related to SARS-CoV-2 infection.
    Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, Godon A, Voulleminot P, Kremer L, Chanson JB, de Seze J.
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32461235
    [No Abstract] [Full Text] [Related]

  • 23. Concomitant Guillain-Barré syndrome and cerebral venous thrombosis complicating a SARS-CoV-2 infection: a case report.
    Qorchi H, Kissani N, Chraa M.
    Pan Afr Med J; 2022 Sep; 42():212. PubMed ID: 36845246
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
    Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC.
    Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
    [Abstract] [Full Text] [Related]

  • 26. A Case of Intractable Hypophosphatemia in a Patient with Guillain-Barré Syndrome and Encephalitis after SARS-CoV-2 Infection.
    Zheng Y, Hou Y, Qi M, Zhang Y, Han C, Sun H, Li J.
    Endocr Metab Immune Disord Drug Targets; 2024 Jan; 24(11):1346-1350. PubMed ID: 38314683
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019.
    Yakoby J, Litvak I, Yu E.
    J Emerg Med; 2021 Oct; 61(4):e67-e70. PubMed ID: 34103203
    [Abstract] [Full Text] [Related]

  • 30. Post COVID-19 Guillain-Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure.
    AlTahan AM, AlAnazi MH, AlTahan FA, AlAbandi FA.
    Neurosciences (Riyadh); 2023 Jan; 28(1):57-61. PubMed ID: 36617454
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Guillain-Barre syndrome and pulmonary embolism in an adult female with COVID-19 infection in Ghana: A case report.
    Tetteh-Wayoe E, Duodu F, Pekyi-Boateng PK, Agyeman Badu NB, Akpalu A, Adjei P.
    Medicine (Baltimore); 2023 May 19; 102(20):e33754. PubMed ID: 37335689
    [Abstract] [Full Text] [Related]

  • 33. Bilateral vocal cord paralysis in Miller Fisher syndrome/Guillain-Barre overlap syndrome and a review of previous case series.
    Bahk J, Yang W, Fishman J.
    BMJ Case Rep; 2021 Jan 27; 14(1):. PubMed ID: 33504540
    [Abstract] [Full Text] [Related]

  • 34. Post-COVID-19 bifacial weakness and paraesthesia: a case report.
    Stuby J, Roth R, Strecker N, Teubner J, Rudiger A.
    Swiss Med Wkly; 2021 Sep 27; 151():w30066. PubMed ID: 34569221
    [Abstract] [Full Text] [Related]

  • 35. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K, Victor N, Buckholtz ES, Hariharan P, Saeed MA, Hershberger DM, Bista S.
    J Investig Med High Impact Case Rep; 2020 Sep 27; 8():2324709620961198. PubMed ID: 32981333
    [Abstract] [Full Text] [Related]

  • 36. A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report.
    Aasfara J, Hajjij A, Bensouda H, Ouhabi H, Benariba F.
    Pan Afr Med J; 2021 Sep 27; 38():30. PubMed ID: 33777298
    [Abstract] [Full Text] [Related]

  • 37. Tuberculous meningitis: An unlikely cause of Guillain-Barre syndrome.
    Nishanth D, Rahul K, Ashok K, Sanjay C.
    Indian J Tuberc; 2020 Jan 27; 67(1):139-142. PubMed ID: 32192609
    [Abstract] [Full Text] [Related]

  • 38. Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
    Ryoo N, Son H, Kim JH, Bae DW, An JY.
    J Korean Med Sci; 2024 Feb 05; 39(5):e48. PubMed ID: 38317448
    [Abstract] [Full Text] [Related]

  • 39. SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome.
    Lascano AM, Epiney JB, Coen M, Serratrice J, Bernard-Valnet R, Lalive PH, Kuntzer T, Hübers A.
    Eur J Neurol; 2020 Sep 05; 27(9):1751-1753. PubMed ID: 32478936
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.